Combined effect of ipilimumab and nivolumab improves oncology endpoints in metastatic melanoma patients is a research paper published in Biotechnology and Genetic Engineering Reviews (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Ministry of Education and King Abdulaziz University, Deanship of Scientific Research, Jeddah, Saudi Arabia
FWCI
0.00
Citation Percentile
0.0%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals